Future long-term studies should be conducted to confirm that astaxanthin inhibits the early phase of obesity-related colon tumorigenesis by improving insulin resistance and the imbalance of adipokines in several animal models. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.